Inhibition of METTL3 Attenuates Renal Fibrosis by Upregulating ABCG2 m6A Modifications via IGF2BP2‐Dependent Mechanisms in Hyperuricemic Nephropathy. The gene discussed is IGF2BP2; the disease is renal fibrosis.